Nerissa T. Viola-Villegas, Ph.D.

Affiliations: 
2009 Chemistry Syracuse University, Syracuse, NY, United States 
Area:
Inorganic Chemistry, Pharmaceutical Chemistry
Google:
"Nerissa Viola-Villegas"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Robert Patrick Doyle grad student 2009 Syracuse
 (Gaining cellular entry via vitamin B-conjugates.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

McKnight BN, Kuda-Wedagedara ANW, Sevak KK, et al. (2018) Imaging EGFR and HER3 through Zr-labeled MEHD7945A (Duligotuzumab). Scientific Reports. 8: 9043
Kuda-Wedagedara ANW, Workinger JL, Nexo E, et al. (2017) (89)Zr-Cobalamin PET Tracer: Synthesis, Cellular Uptake, and Use for Tumor Imaging. Acs Omega. 2: 6314-6320
Demoin DW, Edwards KJ, Wyatt LC, et al. (2016) Abstract 4205: Targeting a variety of cancers with NOTA-derivatized pH (low) insertion peptide (pHLIP) complexes with64Cu and18F: What cancers are targetable Cancer Research. 76: 4205-4205
Emmetiere F, Irwin C, Viola-Villegas NT, et al. (2013) (18)F-labeled-bioorthogonal liposomes for in vivo targeting. Bioconjugate Chemistry. 24: 1784-9
Viola-Villegas N, Rabideau AE, Bartholoma M, et al. (2009) Targeting the cubilin receptor through the vitamin B12 uptake pathway: Cytotoxicity and mechanistic insight through fluorescent Re(I) delivery Journal of Medicinal Chemistry. 52: 5253-5261
Viola-Villegas N, Doyle RP. (2009) The coordination chemistry of 1,4,7,10-tetraazacyclododecane-N,N′,N″,N′″-tetra acetic acid (H4DOTA): Structural overview and analyses on structure-stability relationships Coordination Chemistry Reviews. 253: 1906-1925
Viola-Villegas N, Rabideau AE, Cesnavicious J, et al. (2008) Targeting the folate receptor (FR): Imaging and cytotoxicity of Re I conjugates in FR-overexpressing cancer cells Chemmedchem. 3: 1387-1394
Viola-Villegas N, Vortherms A, Doyle RP. (2008) Targeting Gallium to Cancer Cells through the Folate Receptor Drug Target Insights. 3: DTI.S651
See more...